NO20056199L - Kaptoprilderivater - Google Patents
KaptoprilderivaterInfo
- Publication number
- NO20056199L NO20056199L NO20056199A NO20056199A NO20056199L NO 20056199 L NO20056199 L NO 20056199L NO 20056199 A NO20056199 A NO 20056199A NO 20056199 A NO20056199 A NO 20056199A NO 20056199 L NO20056199 L NO 20056199L
- Authority
- NO
- Norway
- Prior art keywords
- captopril
- captoprilnitro
- prophylaxis
- cardiovascular
- inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101553 | 2003-05-28 | ||
| PCT/EP2004/050899 WO2004106300A1 (en) | 2003-05-28 | 2004-05-24 | Captopril derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20056199L true NO20056199L (no) | 2006-02-13 |
Family
ID=33483995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20056199A NO20056199L (no) | 2003-05-28 | 2005-12-27 | Kaptoprilderivater |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7169805B2 (es) |
| EP (1) | EP1626955A1 (es) |
| JP (1) | JP4649410B2 (es) |
| KR (1) | KR20060013413A (es) |
| CN (1) | CN1795173A (es) |
| AR (1) | AR044568A1 (es) |
| AU (1) | AU2004242799A1 (es) |
| BR (1) | BRPI0410020A (es) |
| CA (1) | CA2527382A1 (es) |
| MX (1) | MXPA05012758A (es) |
| NO (1) | NO20056199L (es) |
| PL (1) | PL379168A1 (es) |
| RU (1) | RU2005135695A (es) |
| WO (1) | WO2004106300A1 (es) |
| ZA (1) | ZA200509459B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| RU2007110846A (ru) | 2004-08-26 | 2008-10-10 | Николас Пайрамал Индия Лимитед (In) | Пролекарства, включающие новые биодеградируемые линкеры |
| WO2011160974A2 (en) | 2010-06-21 | 2011-12-29 | Nicox S.A. | Statin derivatives |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
| JPS559058A (en) * | 1978-07-06 | 1980-01-22 | Dainippon Pharmaceut Co Ltd | 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative |
| US4399144A (en) * | 1980-04-30 | 1983-08-16 | John Wyeth And Brother Limited | Pyridinium salts |
| WO1990002118A1 (en) | 1988-08-26 | 1990-03-08 | Sepracor, Inc. | Derivatives and precursors of captopril and its analogues |
| US5380758A (en) * | 1991-03-29 | 1995-01-10 | Brigham And Women's Hospital | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| AU1670995A (en) * | 1994-01-28 | 1995-08-15 | Cal International Limited | A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |
| UA58494C2 (uk) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
| GB9517998D0 (en) * | 1995-09-04 | 1995-11-08 | Bioglan Lab Ltd | Compositions and device for their administration |
| IT1276071B1 (it) | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
| US6294517B1 (en) * | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| JPH09291075A (ja) * | 1996-03-01 | 1997-11-11 | Sankyo Co Ltd | チアゾリジン類 |
| US6331543B1 (en) * | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| IT1295694B1 (it) * | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| IT1292426B1 (it) * | 1997-06-27 | 1999-02-08 | Nicox Sa | Sali nitrati di ace-inibitori |
| JPH1171279A (ja) | 1997-08-27 | 1999-03-16 | Sankyo Co Ltd | チアゾリジン類を有効成分として含有する狭心症予防剤又は治療剤 |
| US6223744B1 (en) * | 1999-03-16 | 2001-05-01 | Multi-Vet Ltd. | Wearable aerosol delivery apparatus |
| IT1311924B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311923B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| CA2383252A1 (en) * | 1999-08-24 | 2001-03-01 | Medicure International Inc. | Treatment of cardiovascular related pathologies |
| EE05670B1 (et) * | 1999-08-30 | 2013-08-15 | Aventis Pharma Deutschland Gmbh | Ramipriil kardiovaskulaarsete haigusjuhtude rahoidmiseks |
| WO2001054677A2 (en) * | 2000-01-26 | 2001-08-02 | Warner-Lambert Company | Ace inhibitor-vasopressin antagonist combinations |
| AU5939901A (en) * | 2000-10-27 | 2002-05-06 | Nitromed Inc | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| ITMI20011240A1 (it) * | 2001-06-13 | 2002-12-13 | Nicox Sa | Farmaci per le vasculopatie |
-
2004
- 2004-05-20 US US10/849,560 patent/US7169805B2/en not_active Expired - Fee Related
- 2004-05-24 AU AU2004242799A patent/AU2004242799A1/en not_active Abandoned
- 2004-05-24 EP EP04741637A patent/EP1626955A1/en not_active Withdrawn
- 2004-05-24 MX MXPA05012758A patent/MXPA05012758A/es active IP Right Grant
- 2004-05-24 RU RU2005135695/04A patent/RU2005135695A/ru not_active Application Discontinuation
- 2004-05-24 CN CNA2004800145185A patent/CN1795173A/zh active Pending
- 2004-05-24 BR BRPI0410020-4A patent/BRPI0410020A/pt not_active IP Right Cessation
- 2004-05-24 WO PCT/EP2004/050899 patent/WO2004106300A1/en active Application Filing
- 2004-05-24 KR KR1020057022245A patent/KR20060013413A/ko not_active Application Discontinuation
- 2004-05-24 PL PL379168A patent/PL379168A1/pl not_active Application Discontinuation
- 2004-05-24 JP JP2006530215A patent/JP4649410B2/ja not_active Expired - Fee Related
- 2004-05-24 CA CA002527382A patent/CA2527382A1/en not_active Abandoned
- 2004-05-27 AR ARP040101833A patent/AR044568A1/es unknown
-
2005
- 2005-11-22 ZA ZA200509459A patent/ZA200509459B/en unknown
- 2005-12-27 NO NO20056199A patent/NO20056199L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2527382A1 (en) | 2004-12-09 |
| AR044568A1 (es) | 2005-09-21 |
| CN1795173A (zh) | 2006-06-28 |
| RU2005135695A (ru) | 2006-05-27 |
| AU2004242799A1 (en) | 2004-12-09 |
| PL379168A1 (pl) | 2006-07-24 |
| US7169805B2 (en) | 2007-01-30 |
| MXPA05012758A (es) | 2006-02-13 |
| BRPI0410020A (pt) | 2006-04-25 |
| US20040259808A1 (en) | 2004-12-23 |
| JP4649410B2 (ja) | 2011-03-09 |
| JP2006528230A (ja) | 2006-12-14 |
| EP1626955A1 (en) | 2006-02-22 |
| ZA200509459B (en) | 2006-11-29 |
| KR20060013413A (ko) | 2006-02-09 |
| WO2004106300A1 (en) | 2004-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| CL2008001234A1 (es) | Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer. | |
| IS7684A (is) | Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand | |
| NO20054905D0 (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| NO20070782L (no) | Tetrapeptidanaloger. | |
| IS7840A (is) | 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| DK1352896T3 (da) | Adamantanderivater til behandling af inflammations-, immun- og hjertekarsygdomme | |
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| WO2007044534A3 (en) | Vegf analogs and methods of use | |
| NO20081349L (no) | Pyrrolopyrimidinderivater som Syk-inhibitorer | |
| DK1761266T3 (da) | Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme | |
| NO20073574L (no) | Triazolsubstituerte aminobenzofenonforbindelser | |
| WO2007047608A3 (en) | Fibrin targeted therapeutics | |
| ATE448232T1 (de) | Substituierte heterozyklen | |
| DK1919466T3 (da) | Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat | |
| MX2007011493A (es) | Modalidades antiinflamatorias. | |
| WO2002060374A3 (en) | Benz-1,3-azole derivatives and their uses as heparanase inhibitors | |
| ATE531721T1 (de) | Cyanoaminochinolone als gsk-3-inhibitoren | |
| PH12020551573A1 (en) | Pharmaceutical compositions for inhibiting inflammatory cytokines | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
| TW200740755A (en) | Dihalogenation of N,O-disubstituted hydroxypyridones and their uses | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| DK2185561T3 (da) | Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |